Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4PYG

Transglutaminase2 complexed with GTP

Summary for 4PYG
Entry DOI10.2210/pdb4pyg/pdb
DescriptorProtein-glutamine gamma-glutamyltransferase 2, GUANOSINE-5'-TRIPHOSPHATE (3 entities in total)
Functional Keywordsprotein-gtp complex, transglutaminase fold, crosslinking, gtp binding, no modification, transferase
Biological sourceHomo sapiens (human)
Total number of polymer chains3
Total formula weight237021.10
Authors
Park, H.H.,Jang, T.H. (deposition date: 2014-03-27, release date: 2015-02-11, Last modification date: 2024-10-30)
Primary citationJang, T.H.,Lee, D.S.,Choi, K.,Jeong, E.M.,Kim, I.G.,Kim, Y.W.,Chun, J.N.,Jeon, J.H.,Park, H.H.
Crystal structure of transglutaminase 2 with GTP complex and amino acid sequence evidence of evolution of GTP binding site.
Plos One, 9:e107005-e107005, 2014
Cited by
PubMed Abstract: Transglutaminase2 (TG2) is a multi-functional protein involved in various cellular processes, including apoptosis, differentiation, wound healing, and angiogenesis. The malfunction of TG2 causes many human disease including inflammatory disease, celiac disease, neurodegenerative diseases, tissue fibrosis, and cancers. Protein cross-linking activity, which is representative of TG2, is activated by calcium ions and suppressed by GTP. Here, we elucidated the structure of TG2 in complex with its endogenous inhibitor, GTP. Our structure showed why GTP is the optimal nucleotide for interacting with and inhibiting TG2. In addition, sequence comparison provided information describing the evolutionary scenario of GTP usage for controlling the activity of TG2.
PubMed: 25192068
DOI: 10.1371/journal.pone.0107005
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

237992

数据于2025-06-25公开中

PDB statisticsPDBj update infoContact PDBjnumon